This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is a challenge often faced by focal firms that global source? A) lack of ... (Read 66 times)

cool

  • Hero Member
  • *****
  • Posts: 570
Which of the following is a challenge often faced by focal firms that global source?
 
  A) lack of influence over corporate growth
  B) domestic management of local distribution
  C) cost of traveling both domestically and abroad
  D) lower-than-expected cost savings

Question 2

The World Bank Group is an example of which of the following?
 
  A) factoring house
  B) government assistance program
  C) multilateral development bank
  D) commercial bank



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kbennett34

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

Thank you soo much

Answer to Question 2

C




cool

  • Member
  • Posts: 570
Reply 2 on: Jul 7, 2018
Thanks for the timely response, appreciate it


lcapri7

  • Member
  • Posts: 350
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

If all the neurons in the human body were lined up, they would stretch more than 600 miles.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

In 1886, William Bates reported on the discovery of a substance produced by the adrenal gland that turned out to be epinephrine (adrenaline). In 1904, this drug was first artificially synthesized by Friedrich Stolz.

Did you know?

Asthma-like symptoms were first recorded about 3,500 years ago in Egypt. The first manuscript specifically written about asthma was in the year 1190, describing a condition characterized by sudden breathlessness. The treatments listed in this manuscript include chicken soup, herbs, and sexual abstinence.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library